Skip to main content

Want a detailed portfolio tracker?

PepGen (PEPG) P/E (2022 - 2026)

PepGen (PEPG) P/E from Jun 30, 2022 to Jul 20, 2026. The TTM PepGen (PEPG) P/E is -0.93. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of PepGen (PEPG)

YearP/EChange
2026-0.93-60.61%
2025-2.36+91.71%
2024-1.23-41.78%
2023-2.11-68.66%
2022-6.74N/A

Comparison PepGen (PEPG) P/E with competitors

PepGen (PEPG) P/E is -0.93.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.18%
NBYStablecoin Development Corp0.00-100.46%
ENLVEnlivex Ltd0.07-108.05%
FGENFibroGen Inc0.24-125.83%
CHRSCoherus Biosciences Inc0.85-191.32%
FBIOFortress Biotech Inc0.95-202.13%
ORMPOramed Pharmaceuticals Inc1.50-261.76%
AGENAgenus Inc3.01-423.89%
INVAInnoviva Inc3.15-439.43%
VXRTVaxart Inc3.55-482.01%
CRMDCorMedix Inc3.63-490.48%
CVACCureVac N.V.4.45-578.43%
GLPGGalapagos NV4.86-622.90%
SRPTSarepta Therapeutics Inc4.88-625.40%
ABEOAbeona Therapeutics Inc5.39-679.79%
ABUSArbutus Biopharma Corp5.60-702.19%
ZVRAZevra Therapeutics Inc5.89-733.57%
SPROSpero Therapeutics Inc6.23-770.29%
CGENCompugen Ltd6.31-779.49%
RIGLRigel Pharmaceuticals6.87-839.55%
SLXNSilexion Therapeutics Corp7.30-885.19%
OMEROmeros Corporation9.26-1096.40%
AUPHAurinia Pharmaceuticals Inc9.58-1131.51%
PLXProtalix BioTherapeutics Inc10.89-1272.06%
ACADAcadia Pharmaceuticals Inc11.73-1362.20%
TBPHTheravance Biopharma Inc12.26-1419.62%
ADMAAdma Biologics Inc12.42-1436.41%
HRMYHarmony Biosciences Holdings Inc13.82-1587.30%
SABSSAB Biotherapeutics Inc14.14-1621.31%
NAGENiagen Bioscience Inc14.82-1694.69%
INCYIncyte Corp15.82-1802.79%
REGNRegeneron Pharmaceuticals Inc15.86-1806.46%
PBYIPuma Biotechnology Inc17.32-1963.48%
CPRXCatalyst Pharmaceuticals Inc17.44-1976.78%
EXELExelixis Inc17.54-1987.40%
TGTXTG Therapeutics Inc18.97-2141.09%
MDXGMimedx Group Inc20.55-2311.82%
XOMAXOMA Royalty Corp22.87-2561.79%
ARGXArgen X SE24.30-2714.97%
CTMXCytomX Therapeutics Inc24.82-2771.27%
XOMAOXOMA Royalty Corp25.34-2827.63%
HALOHalozyme Therapeutics Inc25.62-2857.64%
XOMAPXOMA Royalty Corp25.67-2862.64%
VRTXVertex Pharmaceuticals Inc27.99-3112.81%
RPRXRoyalty Pharma plc - Class A28.69-3187.37%
SLNOSoleno Therapeutics Inc29.02-3222.65%
ASNDAscendis Pharma A/S30.09-3337.83%
LGNDLigand Pharmaceuticals Inc - Class B37.91-4180.12%
APLSApellis Pharmaceuticals Inc39.02-4299.49%
BMRNBiomarin Pharmaceutical Inc42.21-4642.87%
KRYSKrystal Biotech Inc45.34-4979.90%
ONCBeiGene Ltd69.54-7584.00%
PHARPharming Group N.V.75.03-8174.31%
TECHBio-Techne Corp101.96-11072.84%
VCELVericel Corp109.92-11929.82%
ALNYAlnylam Pharmaceuticals Inc117.96-12795.50%
GMABGenmab140.29-15198.21%
TLXTelix Pharmaceuticals Ltd162.15-17551.02%
CORTCorcept Therapeutics Inc212.86-23007.90%